Pharmaceutical giants to pay Baltimore $266M in opioid epidemic lawsuit
A jury found McKesson and Cencora liable for $266 million in damages to the city of Baltimore for fueling the opioid crisis.
Investor's Business Daily on MSN4d
McKesson Stock Gets A RS Rating Lift To 75
Rating for McKesson stock jumped into a new percentile Wednesday, as it got a lift from 70 to 75. Please watch the video at ...
MarketWatch4d
McKesson Corp. stock underperforms Wednesday when compared to competitors despite daily gains
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
McKesson, Cencora slapped with $266M in damages in Baltimore opioid lawsuit
McKesson (MCK) and Cencora (COR) ordered by a jury in Baltimore to pay $266M in damages to the city for their role in causing ...
Zacks.com on MSN5d
All You Need to Know About McKesson (MCK) Rating Upgrade to Buy
Investors might want to bet on McKesson (MCK), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...
WBAL-TV5d
Jury in Baltimore opioid lawsuit: McKesson, Amerisource-Bergen must pay more than $266M in damages
A Baltimore jury found two drug distributors liable for contributing to the city's ongoing opioid crisis. The decision came ...